Algo version: 0.98b
GT Biopharma Inc is listed at the EURONEXT Exchange
GT Biopharma Inc [GTBP.PA]
EURONEXT Sector: Healthcare Industry:Biotechnology

Is GT Biopharma Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for GT Biopharma Inc 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was €1.030, you would have made a profit of €8.32 per share or 807.77%

We do not have enough data to give you this answer.

GT Biopharma Inc has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for GT Biopharma Inc to be medium [0.6 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.